307 related articles for article (PubMed ID: 12366839)
21. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.
Sponer M; Nick HP; Schnebli HP
Biol Chem Hoppe Seyler; 1991 Nov; 372(11):963-70. PubMed ID: 1686554
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
Zaiou M; Nizet V; Gallo RL
J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
[TBL] [Abstract][Full Text] [Related]
23. Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.
Wnorowska U; Niemirowicz K; Myint M; Diamond SL; Wróblewska M; Savage PB; Janmey PA; Bucki R
Antimicrob Agents Chemother; 2015 Jul; 59(7):3808-15. PubMed ID: 25870055
[TBL] [Abstract][Full Text] [Related]
24. LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid.
McCrudden MT; Orr DF; Yu Y; Coulter WA; Manning G; Irwin CR; Lundy FT
J Clin Periodontol; 2013 Oct; 40(10):933-41. PubMed ID: 23952216
[TBL] [Abstract][Full Text] [Related]
25. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
Wang G
J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
[TBL] [Abstract][Full Text] [Related]
26. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa.
Byfield FJ; Kowalski M; Cruz K; Leszczyńska K; Namiot A; Savage PB; Bucki R; Janmey PA
J Immunol; 2011 Dec; 187(12):6402-9. PubMed ID: 22095714
[TBL] [Abstract][Full Text] [Related]
27. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.
Kilsgård O; Andersson P; Malmsten M; Nordin SL; Linge HM; Eliasson M; Sörenson E; Erjefält JS; Bylund J; Olin AI; Sørensen OE; Egesten A
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):240-8. PubMed ID: 21960546
[TBL] [Abstract][Full Text] [Related]
28. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins.
Twining SS; Kirschner SE; Mahnke LA; Frank DW
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2699-712. PubMed ID: 8344792
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds.
Cole AM; Shi J; Ceccarelli A; Kim YH; Park A; Ganz T
Blood; 2001 Jan; 97(1):297-304. PubMed ID: 11133774
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.
Tang A; Caballero AR; Marquart ME; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2821-8. PubMed ID: 23548618
[TBL] [Abstract][Full Text] [Related]
31. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
[TBL] [Abstract][Full Text] [Related]
32. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.
Holder IA; Haidaris CG
Can J Microbiol; 1979 May; 25(5):593-9. PubMed ID: 89891
[TBL] [Abstract][Full Text] [Related]
33. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.
Tjabringa GS; Aarbiou J; Ninaber DK; Drijfhout JW; Sørensen OE; Borregaard N; Rabe KF; Hiemstra PS
J Immunol; 2003 Dec; 171(12):6690-6. PubMed ID: 14662872
[TBL] [Abstract][Full Text] [Related]
34. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.
Nagant C; Pitts B; Nazmi K; Vandenbranden M; Bolscher JG; Stewart PS; Dehaye JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5698-708. PubMed ID: 22908164
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial activities of heparin-binding peptides.
Andersson E; Rydengård V; Sonesson A; Mörgelin M; Björck L; Schmidtchen A
Eur J Biochem; 2004 Mar; 271(6):1219-26. PubMed ID: 15009200
[TBL] [Abstract][Full Text] [Related]
36. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
Nan YH; Bang JK; Jacob B; Park IS; Shin SY
Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
[TBL] [Abstract][Full Text] [Related]
37. Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.
Mishra B; Wang G
Biofouling; 2017 Aug; 33(7):544-555. PubMed ID: 28675109
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.
Iacob SA; Iacob DG
Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632
[TBL] [Abstract][Full Text] [Related]
39. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
[TBL] [Abstract][Full Text] [Related]
40. Thymic stromal lymphopoietin exerts antimicrobial activities.
Sonesson A; Kasetty G; Olin AI; Malmsten M; Mörgelin M; Sørensen OE; Schmidtchen A
Exp Dermatol; 2011 Dec; 20(12):1004-10. PubMed ID: 22092577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
